Skip to content

Role of Homoeopathy in Pre - Hypertension

Influence of Accessory Circumstances in The Development of Pre - Hypertension & Its Treatment with Individualized Homoeopathic Medicine - A Prospective Placebo Controlled Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053060
Enrollment
65
Registered
2023-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R03- Abnormal blood-pressure reading, without diagnosis

Interventions

Intervention1: Homoeopathic Medicine: Oral route of administration pill form 30 pill size centesimal scale. First Dose during baseline treatment. Repetition according to follow up. Follow up every 4 w

Sponsors

Bakson Homoeopathic Medical College & Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient fulfilling criteria of Pre-Hypertension as per textbook - Harrison â?? Principles of Internal Medicine. 2.Cases in Pre-Hypertension (Systolic - 120 â?? 139 mmHg / Diastolic - 80-89 mmHg) as per textbook â?? Harrison â?? Principles of Internal Medicine. 3.Cases with at least 4 follow-ups

Exclusion criteria

Exclusion criteria: Patient fulfilling criteria of secondary hypertension. Cases in Stage 1 Hypertension and Stage 2 Hypertension. Cases with Isolated Systolic Hypertension Patients on Anti-Hypertensive Therapy Patients who are on oral contraceptive pills or who are pregnant.

Design outcomes

Primary

MeasureTime frame
The outcome of study will be assessed through the readings of blood pressure and questionnaire based on WHOQOL â?? Brief Scale after intervention so that influence of accessory circumstances in the development of Pre-Hypertension can be seen as well as efficacy of homoeopathic individualized medicine in Pre-Hypertension can also be judged so that further studies can also be performed.Timepoint: WHO QOL will be used at baseline, 4 weeks, 8 weeks, 12 weeks till 24 weeks

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Rashid Akhtar

Bakson Homoeopathic Medical College & Hospital

drankurshuklarzt@gmail.com9643940065

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026